Patents by Inventor Johan Hjartstam

Johan Hjartstam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1
    Publication number: 20230011269
    Abstract: The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonaphthalen-1-yl)pyridine-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.
    Type: Application
    Filed: June 23, 2022
    Publication date: January 12, 2023
    Inventors: Joanne REILAND WAKEMAN, Colin ROWLINGS, Sha LIU, Gerry BURKE, Christian VON CORSWANT, Christer TANNERGREN, Johan HJÄRTSTAM
  • PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1
    Publication number: 20210113472
    Abstract: The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonapthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.
    Type: Application
    Filed: August 31, 2020
    Publication date: April 22, 2021
    Inventors: Joanne REILAND WAKEMAN, Colin ROWLINGS, Sha LIU, Gerry BURKE, Christian VON CORSWANT, Christer TANNERGREN, Johan HJÄRTSTAM
  • PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1
    Publication number: 20180360761
    Abstract: The present invention relates to pharmaceutical compositions containing 2-((3-(4-cyanonaphthalen-1-yl)pyridine-4-yl)thio)-2-methylpropanoic acid or a pharmaceutically acceptable salt (hereinafter referred to as the “Agent”), more particularly to orally deliverable compositions containing the Agent; to the use of said compositions as a medicament; and to processes for the preparation of said compositions.
    Type: Application
    Filed: December 7, 2016
    Publication date: December 20, 2018
    Applicants: Ardea Biosciences, Inc., AstraZeneca AB
    Inventors: Joanne REILAND WAKEMAN, Colin ROWLINGS, Sha LIU, Gerry BURKE, Christian VON CORSWANT, Christer TANNERGREN, Johan HJÄRTSTAM
  • Aqueous Film Coating Composition / 841
    Publication number: 20100303920
    Abstract: The invention relates to a film coating composition for use in coating a pharmaceutical formulation, said composition comprising a dispersion which comprises an acrylic polymer; a surfactant containing repeating ethoxy groups; a water-containing liquid; and a polyvinyl alcohol-polyethylene glycol graft copolymer.
    Type: Application
    Filed: November 17, 2009
    Publication date: December 2, 2010
    Inventor: Johan Hjartstam
  • Film coating
    Publication number: 20050256255
    Abstract: The present invention provides a novel film coating dispersion obtainable by the polymerization of the following monomers in water: acrylic acid or an ester thereof in the range 40 to 80% by weight; methacrylic acid or an ester thereof in the range 20 to 60% by weight; and a polymerizable surfactant in the range 0.01 to 9% by weight. The dispersion is suitable for coating pharmaceutical formulations to provide controlled release of the active ingredient.
    Type: Application
    Filed: April 9, 2003
    Publication date: November 17, 2005
    Inventors: Ola Karlsson, Lars Johan Hjartstam, Staffan Schantz
  • New film coating
    Publication number: 20050089574
    Abstract: A film coating composition suitable for use in coating pharmaceutical formulations to provide modified release comprising a dispersion which includes: a) an acrylic polymer, b) a vinyl acetate polymer, and c) a water-containing liquid. The film coat is useful for the achievement of modified release from pharmaceutical formulations such as tablets, pellets, etc.
    Type: Application
    Filed: September 16, 2004
    Publication date: April 28, 2005
    Inventors: Jan-Erik Lofroth, Staffan Schantz, Anders Welin, Lars, Johan, , Hjartstam